Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Alternate Health Club vs Queen RX

Alternate Health Club
Graded #111

Higher grade

vs+3.5
Queen RX
Graded #192

Lower grade

The verdict

Alternate Health Club takes it — 69.8/100 to 66.3/100.

Alternate Health Club grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Alternate Health Club (alternatehealthclub.com) is a LegitScript-verified compounded GLP-1 telehealth platform offering compounded semaglutide at $129/month and compounded tirzepatide at $169/month.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAlternate Health Club +7
84
77
Dose & formulationAlternate Health Club +7
64
57
Clinical oversightAlternate Health Club +8
77
69
Labs & monitoringQueen RX +1
52
53
FulfillmentQueen RX +5
70
75
Contract termsQueen RX +6
55
61
Alternate Health Club · left barQueen RX · right bar

The numbers

MetricAlternate Health ClubQueen RX
WeighScore69.8/10066.3/100
GradeCC
Scorecard rank#111#192
Semaglutide$129/mo (compounded)$100/mo (quarterly plan, compounded)
Tirzepatide$169/mo (compounded)Not disclosed
CoverageCoverage not published45 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Alternate Health Club

Graded #111 · C

Strengths

  • $129/month compounded semaglutide is among the cheapest in the US market
  • $169/month compounded tirzepatide is competitive with established platforms
  • Complimentary workout and dietary plans bundled with medication — most peers don't
  • LegitScript verified
  • US-licensed clinicians

Where it loses points

  • Parent company / legal entity not publicly disclosed
  • State of incorporation not disclosed
  • Per-state availability not listed — confirm your state ships before committing
  • Pharmacy partners not publicly named
  • Unclear whether lab work is included
Queen RX

Graded #192 · C

Strengths

  • $299/quarter (~$100/mo) — among the lowest GLP-1 pricing in the dataset
  • Three GLP-1 options: semaglutide, tirzepatide, and liraglutide
  • 45-state coverage

Where it loses points

  • No LegitScript or PCAB accreditation
  • No legal entity name or address disclosed
  • No named pharmacy partners
  • Not available in KS, LA, MS, NM, WV

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard